日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial

瑞波替尼治疗NTRK融合阳性晚期实体瘤:一项1/2期试验

Besse, Benjamin; Lin, Jessica J; Bazhenova, Lyudmila; Goto, Koichi; de Langen, Adrianus Johannes; Kim, Dong-Wan; Wolf, Jürgen; Springfeld, Christoph; Popat, Sanjay; Lim, Darren W T; Nagasaka, Misako; Hong, Jung Yong; Baik, Christina S; Hervieu, Alice; Moreno, Victor; Yang, Nong; Kollengode, Kanthi; Yang, Haisu; Xu, Yuanfang; Calvet, Christophe Y; Yuan, Yong; Hammell, Amy B; Drilon, Alexander; Solomon, Benjamin J

Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer

普拉替尼治疗晚期RET融合阳性非小细胞肺癌患者的I/II期ARROW研究的最终疗效和安全性数据

Besse, Benjamin; Subbiah, Vivek; Curigliano, Giuseppe; Bowles, Daniel W; Doebele, Robert C; Mansfield, Aaron S; Baik, Christina S; de Lima Lopes, Gilberto; Paz-Ares, Luis; Taylor, Matthew H; Tan, Daniel S W; Alonso, Guzman; Gadgeel, Shirish M; Kalemkerian, Gregory P; Ou, Sai-Hong Ignatius; van der Wekken, Anthonie J; Becerra, Carlos R; Evangelist, Makenzi; Griesinger, Frank; Liu, Stephen V; Lou, Yanyan; Mazières, Julien; Melear, Jason M; Narang, Mohit; Saxena, Ashish; Thomas, Michael; Wang, Sophia; Thomassen, Amber; Lee, Dae Ho; Kim, Dong-Wan; Gainor, Justin F

Amivantamab Plus Lazertinib in Atypical EGFR-Mutated Advanced Non-Small Cell Lung Cancer: Results From CHRYSALIS-2

阿米万他单抗联合拉泽替尼治疗非典型 EGFR 突变型晚期非小细胞肺癌:CHRYSALIS-2 研究结果

Tomasini, Pascale; Wang, Yongsheng; Li, Yongsheng; Felip, Enriqueta; Wu, Lin; Cui, Jiuwei; Besse, Benjamin; Spira, Alexander I; Neal, Joel W; Goto, Koichi; Baik, Christina S; Marmarelis, Melina E; Ichihara, Eiki; Zhang, Yiping; Lee, Jong-Seok; Lee, Se-Hoon; Yang, James Chih-Hsin; Michels, Sebastian; Anastasiou, Zacharias; Curtin, Joshua C; Lyu, Xuesong; Mahoney, Janine; Demirdjian, Levon; Meyer, Craig S; Zhang, Youyi; Leconte, Isabelle; Lorenzini, Patricia; Knoblauch, Roland E; Trani, Leonardo; Baig, Mahadi; Bauml, Joshua M; Cho, Byoung Chul

Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab

接受帕博利珠单抗治疗的非小细胞肺癌患者的预后和治疗

Rousseau, Adrien; Foulon, Stéphanie; Planchard, David; Remon, Jordi; Barlesi, Fabrice; Lavaud, Pernelle; Frelaut, Maxime; Aldea, Mihaela; Parisi, Claudia; Gazzah, Anas; Le Pechoux, Cécile; Botticella, Angela; Levy, Antonin; Simon-Tillaux, Noémie; Michiels, Stefan; Besse, Benjamin

Gut Dysbiosis as a Potential Guide for Immunotherapy (Dis)Continuation After 2 Years in NSCLC: A Brief Report

肠道菌群失调作为非小细胞肺癌免疫治疗2年后是否继续治疗的潜在指导:简要报告

Bonato, Adele; Parisi, Claudia; Cascetta, Priscilla; Reni, Anna; Meyer, May-Lucie; Riudavets, Mariona; Planchard, David; Besse, Benjamin; Remon, Jordi; Facchinetti, Francesco; Belluomini, Lorenzo; Derosa, Lisa; Barlesi, Fabrice

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

PRognostic and predictive potential Of multiparametric dynamic whole-body 18F-FDG PET Imaging using a Long axial field-of-view (LAFOV) system for FIRST-line chemo-immunotherapy efficacy in advanced non-small cell lung cancer: PROFIL-1 study protocol

采用长轴视野(LAFOV)系统进行多参数动态全身18F-FDG PET成像对晚期非小细胞肺癌一线化疗-免疫疗法疗效的预后和预测潜力:PROFIL-1研究方案

Geier, Margaux; Amrane, Karim; Bourhis, David; Le Roux, Pierre-Yves; Nguyen, Jessica; Dhamelincourt, Estelle; Descourt, Renaud; Quéré, Gilles; Guegan, Marie; Besse, Benjamin; Déandreis, Désirée; Besson, Florent; Faure, Sylvain; Karakatsanis, Nicolas; Salaun, Pierre-Yves; Pavoine, Mathieu; Bourbonne, Vincent; Lucia, François; Abgral, Ronan

Bilateral myelin oligodendrocyte glycoprotein antibody-associated disease after cataract surgery

白内障手术后双侧髓鞘少突胶质细胞糖蛋白抗体相关疾病

Besse, Benjamin; Dos Santos, Amélie; Mille, Mathieu; Bobin, Francois; Schultz, Hugo; Berthomet, Aline; Niemerich, Léo; Muszalski, Anna; Gianrocco, Favia; Leveziel, Nicolas

Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

作者更正:CTLA4阻断可消除KEAP1/STK11相关的PD-(L)1抑制剂耐药性

Skoulidis, Ferdinandos; Araujo, Haniel A; Do, Minh Truong; Qian, Yu; Sun, Xin; Cobo, Ana Galan; Le, John T; Montesion, Meagan; Palmer, Rachael; Jahchan, Nadine; Juan, Joseph M; Min, Chengyin; Yu, Yi; Pan, Xuewen; Arbour, Kathryn C; Vokes, Natalie; Schmidt, Stephanie T; Molkentine, David; Owen, Dwight H; Memmott, Regan; Patil, Pradnya D; Marmarelis, Melina E; Awad, Mark M; Murray, Joseph C; Hellyer, Jessica A; Gainor, Justin F; Dimou, Anastasios; Bestvina, Christine M; Shu, Catherine A; Riess, Jonathan W; Blakely, Collin M; Pecot, Chad V; Mezquita, Laura; Tabbó, Fabrizio; Scheffler, Matthias; Digumarthy, Subba; Mooradian, Meghan J; Sacher, Adrian G; Lau, Sally C M; Saltos, Andreas N; Rotow, Julia; Johnson, Rocio Perez; Liu, Corinne; Stewart, Tyler; Goldberg, Sarah B; Killam, Jonathan; Walther, Zenta; Schalper, Kurt; Davies, Kurtis D; Woodcock, Mark G; Anagnostou, Valsamo; Marrone, Kristen A; Forde, Patrick M; Ricciuti, Biagio; Venkatraman, Deepti; Van Allen, Eliezer M; Cummings, Amy L; Goldman, Jonathan W; Shaish, Hiram; Kier, Melanie; Katz, Sharyn; Aggarwal, Charu; Ni, Ying; Azok, Joseph T; Segal, Jeremy; Ritterhouse, Lauren; Neal, Joel W; Lacroix, Ludovic; Elamin, Yasir Y; Negrao, Marcelo V; Le, Xiuning; Lam, Vincent K; Lewis, Whitney E; Kemp, Haley N; Carter, Brett; Roth, Jack A; Swisher, Stephen; Lee, Richard; Zhou, Teng; Poteete, Alissa; Kong, Yifan; Takehara, Tomohiro; Paula, Alvaro Guimaraes; Parra Cuentas, Edwin R; Behrens, Carmen; Wistuba, Ignacio I; Zhang, Jianjun; Blumenschein, George R; Gay, Carl; Byers, Lauren A; Gibbons, Don L; Tsao, Anne; Lee, J Jack; Bivona, Trever G; Camidge, D Ross; Gray, Jhannelle E; Leighl, Natasha B; Levy, Benjamin; Brahmer, Julie R; Garassino, Marina C; Gandara, David R; Garon, Edward B; Rizvi, Naiyer A; Scagliotti, Giorgio Vittorio; Wolf, Jürgen; Planchard, David; Besse, Benjamin; Herbst, Roy S; Wakelee, Heather A; Pennell, Nathan A; Shaw, Alice T; Jänne, Pasi A; Carbone, David P; Hellmann, Matthew D; Rudin, Charles M; Albacker, Lee; Mann, Helen; Zhu, Zhou; Lai, Zhongwu; Stewart, Ross; Peters, Solange; Johnson, Melissa L; Wong, Kwok K; Huang, Alan; Winslow, Monte M; Rosen, Michael J; Winters, Ian P; Papadimitrakopoulou, Vassiliki A; Cascone, Tina; Jewsbury, Philip; Heymach, John V

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial

在III期EXCLAIM-2试验中,一线Mobocertinib与铂类化疗在EGFR 20号外显子插入阳性转移性非小细胞肺癌患者中的疗效比较

Jänne, Pasi A; Wang, Bin-Chao; Cho, Byoung Chul; Zhao, Jun; Li, Juan; Hochmair, Maximilian; Peters, Solange; Besse, Benjamin; Pavlakis, Nick; Neal, Joel W; Kato, Terufumi; Wu, Yi-Long; Nguyen, Danny; Lin, Junjing; Lin, Jianchang; Vranceanu, Florin; Szumski, Annette; Lin, Huamao M; Fram, Robert J; Mok, Tony S K